http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102552452-B
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ac3ebe9fdfc32689eaead83039b7cd19 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-718 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-20 |
| filingDate | 2012-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2014-08-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6eb27b3b695ac3d0908ce07fd2dbb161 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5663580794bf1fdb5b6f53260746b376 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_347d2396cc0c871689ab5d7212623b5d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d71593e06f508288d12484099d251a48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5ff3375ee59ad7179a08775482bcabb2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d0e1c7b637611eb73176905f1578270e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_70540c0171479411c68ba06e3efec31e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_91246189b231ab60150fd8bd9f271fc0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_88ac96b0416487da0d20b6976f243f4d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_17415582a1e4df7e1ea4c1cb677b4388 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_efea5c1f9c86a11df9894e7f29115395 |
| publicationDate | 2014-08-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-102552452-B |
| titleOfInvention | Pharmaceutical composition used for treating virus B hepatitis and its preparing method and application |
| abstract | The invention provides a pharmaceutical composition used for preventing and treating virus B hepatitis. The pharmaceutical composition is a preparation prepared from the following bulk drugs by weight: 1 to 20 parts of gentrin knotweed, 1 to 15 parts of bushy sophora, 1 to 24 parts of Penthorum chinense Pursh and 1 to 10 parts of coptis. The invention also provides a preparing method and application of the pharmaceutical composition. The pharmaceutical composition provided in the invention can increase the level of mRNA of OAS and PKR in a cell and improve the protein level of OAS and PKR, thereby having a good anti-HBV effect, can improve liver injury, having an obvious liver protecting effect, can increase secretory volume of bile, having a certain gallbladder benefiting effect, has a substantial effect on strengthening capability of mouse peritoneal macrophages in phagocytosing chicken red blood cells, enables the phagocytosis rate of the mouse peritoneal macrophages and phagocytosis indexes to be substantially increased compared to control groups, and has an obvious effect on improving low formation of mouse hemolysin antibodies caused by cyclophosphamide. |
| priorityDate | 2011-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 174.